Prosecution Insights
Last updated: August 14, 2026

Medizinische Hochschule Hannover

8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
3
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (50%)
3
Medium (38%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§101 + other2 (25%)
§103 only3 (38%)
§112 only1 (12%)
Multi-statute (no §101)1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
12% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GHIMIRE, SHANKAR RAJ 1 76.6% +19.3%
SPENCE, JENNIFER SUZANNE 1 66.1% +50.7%
YU, DELPHINUS DOU YI 1 50.0% +0.0%
GOLDBERG, JEANINE ANNE 1 45.9% +40.9%
KAPUSHOC, STEPHEN THOMAS 1 46.7% +53.2%
EMCH, GREGORY S 1 48.8% +43.6%
PARK, HAEJIN S 1 55.1% +38.5%
WEHBE, ANNE MARIE SABRINA 1 57.4% +42.8%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18007200 LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION GOLDBERG, JEANINE ANNE 128d overdue
17631598 ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER EMCH, GREGORY S 53d overdue
18727815 SUCTION-FLUSHING-SYSTEM AND MEDICAL INSTRUMENT GHIMIRE, SHANKAR RAJ 29d
18720993 ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS SPENCE, JENNIFER SUZANNE

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17610611 METHOD FOR COATING A MEDICAL DEVICE AND COATED MEDICAL DEVICE PARK, HAEJIN S 139d overdue
18007200 LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION GOLDBERG, JEANINE ANNE 128d overdue
17631598 ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER EMCH, GREGORY S 53d overdue
17811995 LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY KAPUSHOC, STEPHEN THOMAS 28d overdue
18727815 SUCTION-FLUSHING-SYSTEM AND MEDICAL INSTRUMENT GHIMIRE, SHANKAR RAJ 29d
18720993 ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS SPENCE, JENNIFER SUZANNE
17605180 ARTIFICIAL SIGNALLING MOLECULE WEHBE, ANNE MARIE SABRINA

Top Art Units

Art UnitApps
3795 1
1636 1
1682 1
1683 1
1678 1
1614 1
1634 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18727815 SUCTION-FLUSHING-SYSTEM AND MEDICAL INSTRUMENT GHIMIRE, SHANKAR RAJ 3795 §102§103 Final Rejection 29d Pending Jul 10, 2024
18720993 ALPHARETROVIRUS-BASED PARTICLES FOR DELIVERY OF RNA INTO CELLS SPENCE, JENNIFER SUZANNE §101§103§112 Non-Final OA Pending Jun 17, 2024
18254669 LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY YU, DELPHINUS DOU YI 1636 §103 Final Rejection Pending May 26, 2023
18007200 LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION GOLDBERG, JEANINE ANNE 1682 §101§102§112 Non-Final OA 128d overdue Pending Jan 27, 2023
17811995 LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY KAPUSHOC, STEPHEN THOMAS 1683 §112 Final Rejection 28d overdue Pending Jul 12, 2022
17631598 ANALYTICAL METHOD AND IMMUNOLOGICAL TREATMENT FOR BLADDER CANCER EMCH, GREGORY S 1678 §101 Final Rejection 53d overdue Pending Jan 31, 2022
17610611 METHOD FOR COATING A MEDICAL DEVICE AND COATED MEDICAL DEVICE PARK, HAEJIN S 1614 §103 Final Rejection 139d overdue Pending Nov 11, 2021
17605180 ARTIFICIAL SIGNALLING MOLECULE WEHBE, ANNE MARIE SABRINA 1634 §103 Non-Final OA Pending Oct 20, 2021

Managing Medizinische Hochschule Hannover's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month